Prescription ID | TCMF6691 |
Pinyin Name | Yan Re Qing Jiao Nang |
Chinese Name | 炎热清胶囊 |
English Name | Yan Re Qing Capsules |
Function Description | 咳嗽, 热淋, 胁痛 |
Indications | Hypochondrium pain disorder, Heat stranguria disorder, Acute prostatitis, Chronic prostatitis, Salmonella pyelonephritis, Chronic pyelonephritis, Cystitis, Urethritis |
Disease ICD-11 Category |
SA00 [Hypochondrium pain disorder (TM1), 胁痛 (TM1)
]; SA91 [Heat stranguria disorder (TM1), 热淋 (TM1) ]; GA91.Y [Other specified inflammatory and other diseases of prostate, 其他特指的前列腺炎性疾病 ]; GA91.0 [Chronic prostatitis, 慢性前列腺炎 ]; GC2Z [Diseases of the urinary system, unspecified, 泌尿系统疾病,未特指的 ]; GB55.Z [Chronic tubulo-interstitial nephritis, unspecified, 慢性肾小管-间质肾炎,未特指的 ]; GC00 [Cystitis, 膀胱炎 ]; GC02.Y [Other specified urethritis and urethral syndrome, 其他特指的尿道炎和尿道综合征 ]; |
Human Tissues Associated with Indication | Lung, Bladder |
Reference | CFDA |
Reference Book/link | http://samr.cfda.gov.cn/WS01/CL0001/ |
Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
---|---|---|---|---|
TCMH986 | Scutellaria baicalensis | 黄芩 | TCMH986 | ITSAP4211-14 |
TCMH189 | Mentholum | 薄荷脑 | TCMH189 | |
TCMH2343 | Scrophularia ningpoensis | 玄参 | TCMH2343 | ITSAO4295-14 |
TCMH1317 | Gentiana scabra | 龙胆 | TCMH1317 | ITSAP4208-14 |
TCMH1931 | Gypsum fibrosum | 石膏 | TCMH1931 | |
TCMH228 | Bupleurum chinense | 柴胡 | TCMH228 | ITSAM2218-14 |
TCMH2641 | Gardenia jasminoides | 栀子 | TCMH2641 | ITSAJ4473-14 |
TCMH2624 | Anemarrhena asphodeloides | 知母 | TCMH2624 | GBVA3255-11, GBVU1201-13 |
Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
---|---|---|---|---|
TCMT112 | ADORA3 | Adenosine A3 receptor | GPCR | P0DMS8 |
TCMT126 | TERT | Telomerase reverse transcriptase | Transferase | O14746 |
TCMT127 | PARP1 | Poly [ADP-ribose] polymerase-1 | Transferase | P09874 |
TCMT128 | TNKS2 | Tankyrase-2 | Transferase | Q9H2K2 |
TCMT129 | TNKS | Tankyrase-1 | Transferase | O95271 |
TCMT130 | ALOX5 | Arachidonate 5-lipoxygenase | Oxidoreductase | P09917 |
TCMT131 | ACHE | Acetylcholinesterase | Hydrolase | P22303 |
TCMT133 | CA1 | Carbonic anhydrase I | Lyase | P00915 |
TCMT134 | CA2 | Carbonic anhydrase II | Lyase | P00918 |
TCMT135 | CA14 | Carbonic anhydrase XIV | Lyase | Q9ULX7 |
TCMT136 | CA12 | Carbonic anhydrase XII | Lyase | O43570 |
TCMT137 | CA9 | Carbonic anhydrase IX | Lyase | Q16790 |
TCMT138 | CA7 | Carbonic anhydrase VII | Lyase | P43166 |
TCMT142 | CA4 | Carbonic anhydrase IV | Lyase | P22748 |
TCMT156 | CYP19A1 | Cytochrome P450 19A1 | Oxidoreductase | P11511 |
TCMT159 | TYR | Tyrosinase | Oxidoreductase | P14679 |
TCMT161 | HCAR2 | Hydroxycarboxylic acid receptor 2 | GPCR | Q8TDS4 |
TCMT162 | UGT1A1 | UDP-glucuronosyltransferase 1-1 | Transferase | P22309 |
TCMT186 | MAOB | Monoamine oxidase B | Oxidoreductase | P27338 |
TCMT189 | DUSP3 | Dual specificity protein phosphatase 3 | Hydrolase | P51452 |
TCMT2 | MAPT | Microtubule-associated protein tau | Unclassified | P10636 |
TCMT207 | BACE1 | Beta-secretase 1 | Protease | P56817 |
TCMT212 | SRC | Tyrosine-protein kinase SRC | Kinase | P12931 |
TCMT215 | CYP1A1 | Cytochrome P450 1A1 | Oxidoreductase | P04798 |
TCMT217 | CYP2C8 | Cytochrome P450 2C8 | Oxidoreductase | P10632 |
TCMT219 | CYP1A2 | Cytochrome P450 1A2 | Oxidoreductase | P05177 |
TCMT223 | AKR1B1 | Aldose reductase | Oxidoreductase | P15121 |
TCMT23 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Hydrolase | P05186 |
TCMT232 | ABCB1 | P-glycoprotein 1 | Transporter | P08183 |
TCMT239 | PIM1 | Serine/threonine-protein kinase PIM1 | Kinase | P11309 |
TCMT240 | AMY1A | Salivary alpha-amylase | Unclassified | P04745 |
TCMT254 | CBR1 | Carbonyl reductase [NADPH] 1 | Oxidoreductase | P16152 |
TCMT257 | CYP1B1 | Cytochrome P450 1B1 | Oxidoreductase | Q16678 |
TCMT260 | FLT3 | Tyrosine-protein kinase receptor FLT3 | Kinase | P36888 |
TCMT261 | DAPK1 | Death-associated protein kinase 1 | Kinase | P53355 |
TCMT280 | AKR1B10 | Aldo-keto reductase family 1 member B10 | Oxidoreductase | O60218 |
TCMT283 | PTPRS | Receptor-type tyrosine-protein phosphatase S | Hydrolase | Q13332 |
TCMT295 | MMP1 | Matrix metalloproteinase-1 | Hydrolase | P03956 |
TCMT296 | ADORA1 | Adenosine A1 receptor | GPCR | P30542 |
TCMT297 | FABP4 | Fatty acid binding protein adipocyte | Unclassified | P15090 |
TCMT298 | FABP3 | Fatty acid binding protein muscle | Hydrolase | P05413 |
TCMT3 | ALOX15 | Arachidonate 15-lipoxygenase | Oxidoreductase | P16050 |
TCMT304 | MMP14 | Matrix metalloproteinase 14 | Hydrolase | P50281 |
TCMT306 | MMP2 | Matrix metalloproteinase-2 | Hydrolase | P08253 |
TCMT321 | MMP9 | Matrix metalloproteinase 9 | Hydrolase | P14780 |
TCMT322 | MMP13 | Matrix metalloproteinase 13 | Hydrolase | P45452 |
TCMT354 | AURKA | Serine/threonine-protein kinase Aurora-A | Kinase | O14965 |
TCMT369 | IGF1R | Insulin-like growth factor I receptor | Kinase | P08069 |
TCMT370 | KDR | Vascular endothelial growth factor receptor 2 | Kinase | P35968 |
TCMT374 | AURKB | Serine/threonine-protein kinase Aurora-B | Kinase | Q96GD4 |
TCMT377 | INSR | Insulin receptor | Kinase | P06213 |
TCMT384 | GRK6 | G protein-coupled receptor kinase 6 | Kinase | P43250 |
TCMT388 | AXL | Tyrosine-protein kinase receptor UFO | Kinase | P30530 |
TCMT39 | PDE5A | Phosphodiesterase 5A | Hydrolase | O76074 |
TCMT401 | MET | Hepatocyte growth factor receptor | Kinase | P08581 |
TCMT418 | EPHB4 | Ephrin type-B receptor 4 | Kinase | P54760 |
TCMT422 | CAMK2B | CaM kinase II beta | Kinase | Q13554 |
TCMT423 | EGFR | Epidermal growth factor receptor erbB1 | Kinase | P00533 |
TCMT436 | NUAK1 | NUAK family SNF1-like kinase 1 | Kinase | O60285 |
TCMT445 | NEK2 | Serine/threonine-protein kinase NEK2 | Kinase | P51955 |
TCMT45 | APP | Beta amyloid A4 protein | Unclassified | P05067 |
TCMT457 | FLT4 | Vascular endothelial growth factor receptor 3 | Kinase | P35916 |
TCMT462 | NEK6 | Serine/threonine-protein kinase NEK6 | Kinase | Q9HC98 |
TCMT47 | BCL2 | Apoptosis regulator Bcl-2 | Ion channel | P10415 |
TCMT479 | AKT1 | Serine/threonine-protein kinase AKT | Kinase | P31749 |
TCMT484 | PLK1 | Serine/threonine-protein kinase PLK1 | Kinase | P53350 |
TCMT502 | TEK | Tyrosine-protein kinase TIE-2 | Kinase | Q02763 |
TCMT510 | KIT | Stem cell growth factor receptor | Kinase | P10721 |
TCMT536 | PDGFRB | Platelet-derived growth factor receptor beta | Kinase | P09619 |
TCMT560 | F10 | Coagulation factor X | Unclassified | P00742 |
TCMT567 | DNMT1 | DNA (cytosine-5)-methyltransferase 1 | Transferase | P26358 |
TCMT592 | XDH | Xanthine dehydrogenase | Oxidoreductase | P47989 |
TCMT597 | SLC28A3 | Solute carrier family 28 member 3 | Transporter | Q9HAS3 |
TCMT598 | TOP1 | DNA topoisomerase I | Isomerase | P11387 |
TCMT614 | EGLN1 | Egl nine homolog 1 | Oxidoreductase | Q9GZT9 |
TCMT626 | BRAF | Serine/threonine-protein kinase B-raf | Kinase | P15056 |
TCMT63 | PPARA | Peroxisome proliferator-activated receptor alpha | Nuclear receptor | Q07869 |
TCMT637 | SIRT3 | NAD-dependent deacetylase sirtuin 3 | Hydrolase | Q9NTG7 |
TCMT638 | SIRT2 | NAD-dependent deacetylase sirtuin 2 | Hydrolase | Q8IXJ6 |
TCMT65 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | Oxidoreductase | P14061 |
TCMT66 | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | Oxidoreductase | P37059 |
TCMT709 | SLC28A2 | Sodium/nucleoside cotransporter 2 | Transporter | O43868 |
TCMT710 | SLC28A1 | Sodium/nucleoside cotransporter 1 | Transporter | O00337 |
TCMT721 | HSPA1A | Heat shock 70 kDa protein 1 | Unclassified | P0DMV8 |
TCMT739 | GPR35 | G-protein coupled receptor 35 | GPCR | Q9HC97 |
TCMT751 | DYRK1A | Dual-specificity tyrosine-phosphorylation regulated kinase 1A | Kinase | Q13627 |
TCMT752 | CSNK2A1 | Casein kinase II alpha | Kinase | P68400 |
TCMT753 | SMAD3 | Mothers against decapentaplegic homolog 3 | Unclassified | P84022 |
TCMT755 | PLK4 | Serine/threonine-protein kinase PLK4 | Kinase | O00444 |
TCMT756 | MAP3K8 | Mitogen-activated protein kinase kinase kinase 8 | Kinase | P41279 |
TCMT784 | AVPR2 | Vasopressin V2 receptor | GPCR | P30518 |
TCMT785 | CXCR1 | Interleukin-8 receptor A | GPCR | P25024 |
TCMT786 | CCR4 | C-C chemokine receptor type 4 | GPCR | P51679 |
TCMT791 | PKN1 | Protein kinase N1 | Kinase | Q16512 |
TCMT793 | PYGL | Liver glycogen phosphorylase | Transferase | P06737 |
TCMT8 | KDM4E | Lysine-specific demethylase 4D-like | Oxidoreductase | B2RXH2 |
TCMT801 | TUBB3 | Tubulin beta-3 chain | Unclassified | Q13509 |
TCMT808 | FABP5 | Fatty acid binding protein epidermal | Unclassified | Q01469 |
TCMT809 | FABP2 | Fatty acid binding protein intestinal | Unclassified | P12104 |
TCMT810 | TLR2 | Toll-like receptor 2 | Unclassified | O60603 |
TCMT822 | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Transferase | Q11130 |
TCMT87 | CYP2C9 | Cytochrome P450 2C9 | Oxidoreductase | P11712 |
Target ID | Target Name |
---|---|
TCMT1175 | Human immunodeficiency virus |
TCMT1176 | Streptococcus pneumoniae |
TCMT1178 | Actinomyces viscosus |
TCMT1189 | Pseudomonas fluorescens |
TCMT1190 | Plasmodium falciparum (isolate FcB1 / Columbia) |
TCMT1191 | Bacillus megaterium |
TCMT1208 | Escherichia coli K12 |
TCMT1209 | Staphylococcus haemolyticus |
TCMT1210 | Streptococcus sobrinus |
TCMT1211 | Fusobacterium nucleatum |
TCMT1212 | Verticillium dahliae |
TCMT1214 | Enterococcus faecium |
TCMT1215 | Pseudomonas aeruginosa PAO1 |
TCMT1217 | Bacillus anthracis |
TCMT1218 | Staphylococcus aureus |
TCMT1222 | Plasmodium falciparum D6 |
TCMT1223 | Staphylococcus epidermidis |
TCMT1226 | Klebsiella pneumoniae |
TCMT1229 | Enterococcus faecalis |
TCMT1232 | Pseudomonas aeruginosa |
TCMT1236 | Mycobacterium bovis |
TCMT1246 | Escherichia coli |
TCMT1248 | Hepatitis C virus |
TCMT1249 | Dengue virus 2 |
TCMT1251 | Candida albicans |
TCMT1253 | Penicillium chrysogenum |
TCMT1260 | Streptococcus agalactiae |
TCMT1286 | Bacillus cereus |
TCMT1294 | Human parainfluenza virus 3 |
TCMT1296 | Influenza A virus H3N2 |
TCMT1319 | Corynebacterium xerosis |
TCMT1321 | Staphylococcus hominis |
TCMT1322 | Streptococcus mitis |
TCMT1323 | Corynebacterium pseudodiphtheriticum |
TCMT1324 | Corynebacterium diphtheriae |
TCMT1343 | Staphylococcus simulans |
TCMT1344 | Staphylococcus sciuri |
TCMT1346 | Helicobacter pylori |
TCMT1349 | Helicobacter pylori SS1 |
TCMT1361 | Neisseria meningitidis |
TCMT1370 | Prevotella melaninogenica |
TCMT1382 | Plasmodium falciparum (isolate K1 / Thailand) |
TCMT1410 | Listeria monocytogenes |
TCMT1412 | Salmonella typhimurium |
TCMT1438 | Plasmodium falciparum |
TCMT1439 | Mycobacterium smegmatis |
TCMT1442 | Leishmania donovani |
TCMT1443 | Leishmania amazonensis |
TCMT1447 | Respiratory syncytial virus |
TCMT1448 | Enterobacter aerogenes |
TCMT1449 | Influenza A virus |
TCMT1450 | Plasmodium falciparum 3D7 |
TCMT1454 | Bacillus subtilis |
TCMT1455 | Mycobacterium tuberculosis H37Rv |
TCMT1458 | Filobasidiella neoformans |
TCMT1462 | Streptococcus mutans |
TCMT1463 | Mycobacterium tuberculosis |
TCMT1464 | Hepatitis B virus |
TCMT1465 | Entamoeba histolytica |
GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
---|---|---|---|
[BP] GO:0010647 | positive regulation of cell communication | ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, FLT3, GPR35, HCAR2, HSPA1A, INSR, KDR, KIT, MET, MMP9, PDE5A, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 11.1819 |
[BP] GO:0023056 | positive regulation of signaling | ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, FLT3, GPR35, HCAR2, HSPA1A, INSR, KDR, KIT, MET, MMP9, PDE5A, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 11.1819 |
[BP] GO:0042221 | response to chemical | ABCB1, AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOB, MMP2, MMP9, PPARA, SMAD3, SRC, TEK, TERT, TOP1, TYR | 10.0525 |
[BP] GO:0065008 | regulation of biological quality | ABCB1, ACHE, ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, EGFR, F10, FABP3, FABP4, FLT3, GPR35, HCAR2, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, KIT, MAOB, MET, PPARA, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 9.47194 |
[BP] GO:0010035 | response to inorganic substance | AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, KIT, MAOB, MMP9, SRC, TERT | 9.45452 |
[BP] GO:0010646 | regulation of cell communication | ACHE, ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, DYRK1A, EGFR, F10, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP9, NUAK1, PDE5A, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 9.45452 |
[BP] GO:0010033 | response to organic substance | AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOB, MMP2, PPARA, SMAD3, SRC, TEK, TYR | 9.39541 |
[BP] GO:0023051 | regulation of signaling | ACHE, ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, DYRK1A, EGFR, F10, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP9, NUAK1, PDE5A, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 9.37088 |
[BP] GO:0009967 | positive regulation of signal transduction | ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, F10, FLT3, GPR35, HSPA1A, INSR, KDR, KIT, MET, MMP9, PDE5A, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 8.92321 |
[BP] GO:0046777 | protein autophosphorylation | AURKB, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, PIM1, SRC, TEK | 8.50809 |
[BP] GO:0044237 | cellular metabolic process | ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, F10, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOB, MET, MMP1, MMP2, NUAK1, PDE5A, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP1, TYR, XDH | 8.27589 |
[BP] GO:0009719 | response to endogenous stimulus | AKR1B1, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DNMT1, EGFR, FABP3, FLT3, IGF1R, INSR, KIT, MAOB, MMP2, PPARA, SMAD3, SRC, TEK | 8.27589 |
[BP] GO:0042127 | regulation of cell proliferation | ADORA1, ADORA3, AKR1B1, APP, BCL2, CSNK2A1, CYP1B1, DNMT1, EGFR, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MMP2, MMP9, NUAK1, PDE5A, PIM1, SMAD3, SRC, TEK, TERT, XDH | 8.27589 |
[BP] GO:0008152 | metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, F10, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOB, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP1, TYR, XDH | 8.20579 |
[BP] GO:1902531 | regulation of intracellular signal transduction | ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DUSP3, DYRK1A, EGFR, F10, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP9, NUAK1, PDE5A, SRC, TEK, XDH | 8.13358 |
[BP] GO:0048522 | positive regulation of cellular process | ACHE, ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, F10, FABP3, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOB, MET, MMP1, MMP2, MMP9, PDE5A, PIM1, PPARA, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 8.0051 |
[BP] GO:1901700 | response to oxygen-containing compound | AKR1B1, ALPL, APP, AXL, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, FABP3, HSD17B2, IGF1R, INSR, MAOB, MMP2, MMP9, PPARA, SRC, TEK, TYR | 8.0051 |
[BP] GO:0006629 | lipid metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, KIT, MET, PPARA | 7.65436 |
[BP] GO:0048518 | positive regulation of biological process | ABCB1, ACHE, ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, F10, FABP3, FABP4, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOB, MET, MMP1, MMP2, MMP9, PDE5A, PIM1, PPARA, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 7.64867 |
[BP] GO:0018108 | peptidyl-tyrosine phosphorylation | AXL, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK | 7.64729 |
[BP] GO:0018212 | peptidyl-tyrosine modification | AXL, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK | 7.60144 |
[BP] GO:1902533 | positive regulation of intracellular signal transduction | ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CYP1B1, EGFR, F10, FLT3, GPR35, HSPA1A, INSR, KDR, KIT, MET, PDE5A, SRC, TEK, XDH | 7.60144 |
[BP] GO:0006796 | phosphate-containing compound metabolic process | ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CSNK2A1, DUSP3, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PDE5A, PIM1, PTPRS, SRC, TEK, TNKS, TOP1, XDH | 7.53091 |
[BP] GO:0030334 | regulation of cell migration | ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK, TERT | 7.45912 |
[BP] GO:0048584 | positive regulation of response to stimulus | ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, F10, FABP4, FLT3, GPR35, HSPA1A, INSR, KDR, KIT, MET, MMP2, MMP9, PDE5A, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 7.30224 |
[BP] GO:0006793 | phosphorus metabolic process | ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CSNK2A1, DUSP3, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PDE5A, PIM1, PTPRS, SRC, TEK, TNKS, TOP1, XDH | 7.11577 |
[BP] GO:0015701 | bicarbonate transport | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 7.10817 |
[BP] GO:0006468 | protein phosphorylation | APP, AURKB, AXL, BCL2, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, TNKS, TOP1 | 7.07274 |
[BP] GO:2000145 | regulation of cell motility | ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK, TERT | 7.07274 |
[BP] GO:0060548 | negative regulation of cell death | ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TERT | 6.97477 |
[BP] GO:0030335 | positive regulation of cell migration | APP, BCL2, EGFR, F10, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK, TERT | 6.97438 |
[BP] GO:0070887 | cellular response to chemical stimulus | AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MMP2, MMP9, SMAD3, SRC, TERT | 6.94115 |
[BP] GO:0032879 | regulation of localization | ABCB1, ACHE, ADORA1, ADORA3, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOB, MET, MMP9, PPARA, SMAD3, SRC, TEK, TERT | 6.91416 |
[BP] GO:0048583 | regulation of response to stimulus | ABCB1, ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, DYRK1A, EGFR, F10, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, NUAK1, PDE5A, PPARA, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 6.8282 |
[BP] GO:2000147 | positive regulation of cell motility | APP, BCL2, EGFR, F10, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK, TERT | 6.81589 |
[BP] GO:0043069 | negative regulation of programmed cell death | ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, KIT, MET, MMP9, PIM1, SMAD3, SRC, TEK, TERT | 6.76925 |
[BP] GO:0019748 | secondary metabolic process | AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR | 6.75772 |
[BP] GO:0032502 | developmental process | ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, DYRK1A, EGFR, FABP4, FLT3, FUT7, HSD17B2, INSR, KDR, KIT, MAOB, MET, MMP2, MMP9, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TERT, TNKS2, TYR | 6.75456 |
[BP] GO:0009725 | response to hormone | AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, FABP3, FLT3, INSR, KIT, MAOB, PPARA, SRC, TEK | 6.73927 |
[BP] GO:0051272 | positive regulation of cellular component movement | APP, BCL2, EGFR, F10, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK, TERT | 6.71545 |
[BP] GO:0009966 | regulation of signal transduction | ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DUSP3, DYRK1A, EGFR, F10, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP9, NUAK1, PDE5A, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 6.71145 |
[BP] GO:0040012 | regulation of locomotion | ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK, TERT | 6.66074 |
[BP] GO:0051270 | regulation of cellular component movement | ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK, TERT | 6.646 |
[BP] GO:0044281 | small molecule metabolic process | AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, HSPA1A, PDE5A, PIM1, PPARA, TYR, XDH | 6.62341 |
[BP] GO:0010038 | response to metal ion | ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, EGFR, FABP4, KIT, MAOB, MMP9, TERT | 6.59775 |
[BP] GO:0040017 | positive regulation of locomotion | APP, BCL2, EGFR, F10, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK, TERT | 6.58238 |
[BP] GO:0048513 | animal organ development | ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, FLT3, HSD17B2, INSR, KDR, KIT, PPARA, PTPRS, SMAD3, SRC, TEK, TYR | 6.39817 |
[BP] GO:0010941 | regulation of cell death | ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, FLT3, HCAR2, HSPA1A, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TERT, XDH | 6.27362 |
[BP] GO:0032501 | multicellular organismal process | ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, F10, FABP4, HSD17B2, IGF1R, INSR, KIT, MET, MMP1, MMP2, MMP9, PDE5A, PIM1, PPARA, SMAD3, SRC, TEK, TNKS2, TOP1, TYR | 6.19689 |
[BP] GO:0006730 | one-carbon metabolic process | CA1, CA12, CA2, CA4, CA7, CA9 | 6.12978 |
[BP] GO:0043067 | regulation of programmed cell death | ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, FLT3, HCAR2, HSPA1A, IGF1R, KDR, KIT, MET, MMP9, PIM1, SMAD3, SRC, TEK, TERT, XDH | 6.12978 |
[BP] GO:0018193 | peptidyl-amino acid modification | AURKB, AXL, BCL2, CSNK2A1, DYRK1A, EGFR, F10, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK, TNKS, TOP1 | 5.95632 |
[BP] GO:0016310 | phosphorylation | APP, AURKB, AXL, BCL2, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, TNKS, TOP1 | 5.8223 |
[BP] GO:0051130 | positive regulation of cellular component organization | ALOX15, APP, AURKB, AXL, BCL2, DNMT1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 | 5.73035 |
[BP] GO:0048856 | anatomical structure development | ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, DYRK1A, EGFR, FLT3, HSD17B2, INSR, KDR, KIT, MAOB, MMP9, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TYR | 5.71252 |
[BP] GO:1901564 | organonitrogen compound metabolic process | ACHE, AKR1B1, ALPL, APP, AURKB, AXL, BACE1, BCL2, CSNK2A1, CYP1A1, CYP1A2, DUSP3, DYRK1A, EGFR, F10, FLT3, FUT7, HSPA1A, IGF1R, INSR, KDR, KIT, MAOB, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1, TYR, XDH | 5.61238 |
[BP] GO:0071310 | cellular response to organic substance | AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CYP1A1, CYP1B1, DNMT1, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, KIT, MMP2, SMAD3, SRC | 5.48565 |
[BP] GO:0033993 | response to lipid | ALPL, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, FABP3, FLT3, HSD17B2, MAOB, SRC, TYR | 5.43146 |
[BP] GO:0050896 | response to stimulus | ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, F10, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOB, MMP2, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, TERT, TOP1, TYR | 5.42933 |
[BP] GO:0010638 | positive regulation of organelle organization | ALOX15, AURKB, BCL2, DNMT1, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 | 5.41005 |
[BP] GO:0014070 | response to organic cyclic compound | ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FLT3, MAOB, SRC, TEK, TYR | 5.40921 |
[BP] GO:0043066 | negative regulation of apoptotic process | ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MMP9, PIM1, SMAD3, SRC, TEK, TERT | 5.33112 |
[BP] GO:0009628 | response to abiotic stimulus | ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, EGFR, HSPA1A, KIT, MMP2, PPARA, SMAD3, SRC, TEK, TERT, TYR | 5.19186 |
[BP] GO:0044238 | primary metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, F10, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP1, TYR, XDH | 5.1819 |
[BP] GO:0051716 | cellular response to stimulus | AKR1B1, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MMP2, MMP9, NUAK1, SMAD3, SRC, TERT | 5.11811 |
[BP] GO:0071704 | organic substance metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, F10, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOB, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP1, TYR, XDH | 5.09902 |
[BP] GO:0051896 | regulation of protein kinase B signaling | AXL, EGFR, F10, INSR, KIT, MET, SRC, TEK, XDH | 5.05062 |
[BP] GO:0080134 | regulation of response to stress | ABCB1, ADORA1, APP, CYP19A1, DUSP3, DYRK1A, EGFR, FABP4, HSPA1A, IGF1R, MET, MMP2, NUAK1, PPARA, PTPRS, SMAD3, SRC, TEK, TERT, XDH | 5.03942 |
[BP] GO:0048519 | negative regulation of biological process | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, FABP3, FABP4, GPR35, HCAR2, HSPA1A, IGF1R, KDR, KIT, MAOB, MET, MMP9, PDE5A, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 5.01403 |
[BP] GO:0051897 | positive regulation of protein kinase B signaling | AXL, EGFR, F10, INSR, KIT, MET, SRC, TEK | 4.98615 |
[BP] GO:0042981 | regulation of apoptotic process | ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, FLT3, HCAR2, HSPA1A, IGF1R, KDR, MMP9, PIM1, SMAD3, SRC, TEK, TERT, XDH | 4.84575 |
[BP] GO:0048523 | negative regulation of cellular process | ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KDR, KIT, MAOB, MET, MMP9, PDE5A, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 4.84521 |
[BP] GO:0044255 | cellular lipid metabolic process | ACHE, AKR1B10, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, FABP4, FUT7, KIT, MET, PPARA | 4.68074 |
[BP] GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, SRC, TEK | 4.67767 |
[BP] GO:0043408 | regulation of MAPK cascade | ADORA1, ALOX15, APP, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, KIT, PDE5A, SRC, TEK, XDH | 4.67767 |
[BP] GO:0001503 | ossification | ALOX15, ALPL, BCL2, EGFR, MMP2, MMP9, TEK | 4.60576 |
[BP] GO:0043410 | positive regulation of MAPK cascade | ADORA1, ALOX15, APP, EGFR, FLT3, INSR, KDR, KIT, PDE5A, SRC, TEK, XDH | 4.58307 |
[BP] GO:0019220 | regulation of phosphate metabolic process | ADORA1, ALOX15, APP, BCL2, DUSP3, EGFR, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, KIT, MMP9, NUAK1, PDE5A, PPARA, SMAD3, SRC, TEK, XDH | 4.55825 |
[BP] GO:0008202 | steroid metabolic process | AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2 | 4.52599 |
[BP] GO:0051174 | regulation of phosphorus metabolic process | ADORA1, ALOX15, APP, BCL2, DUSP3, EGFR, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, KIT, MMP9, NUAK1, PDE5A, PPARA, SMAD3, SRC, TEK, XDH | 4.50789 |
[BP] GO:0032847 | regulation of cellular pH reduction | BCL2, CA2, CA7 | 4.5046 |
[BP] GO:0009611 | response to wounding | ACHE, ADORA3, ALOX15, BCL2, CYP1A1, EGFR, PPARA, SMAD3 | 4.49571 |
[BP] GO:0031399 | regulation of protein modification process | ADORA1, ALOX15, APP, BCL2, DNMT1, DUSP3, DYRK1A, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MMP9, NUAK1, PDE5A, SRC, TEK, XDH | 4.44142 |
[BP] GO:0001666 | response to hypoxia | ADORA1, BCL2, CYP1A1, MMP2, PPARA, SMAD3, SRC, TEK, TERT | 4.37265 |
[BP] GO:0051098 | regulation of binding | APP, AURKB, BCL2, MET, MMP9, PPARA, SMAD3, SRC, TERT, TNKS | 4.36965 |
[BP] GO:0008283 | cell proliferation | ABCB1, ACHE, AURKB, BCL2, CYP1A1, EGFR, FLT3, KIT, MET, PIM1, SRC, TEK, TYR | 4.33415 |
[BP] GO:0036293 | response to decreased oxygen levels | ADORA1, BCL2, CYP1A1, MMP2, PPARA, SMAD3, SRC, TEK, TERT | 4.27337 |
[BP] GO:0051173 | positive regulation of nitrogen compound metabolic process | ADORA1, ALOX15, APP, AURKB, BCL2, CSNK2A1, DNMT1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MAOB, MET, MMP9, PDE5A, PPARA, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 4.25623 |
[BP] GO:0009056 | catabolic process | ACHE, ADORA1, AKR1B10, AURKB, BACE1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, HSPA1A, MAOB, MMP1, MMP2, MMP9, PDE5A, SRC, XDH | 4.21808 |
[BP] GO:0065009 | regulation of molecular function | ABCB1, ADORA1, ADORA3, APP, AURKB, BCL2, CSNK2A1, CYP1B1, DUSP3, EGFR, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KIT, MET, MMP9, NUAK1, PDE5A, PIM1, PPARA, SMAD3, SRC, TEK, TERT, TNKS, XDH | 4.21808 |
[BP] GO:0007167 | enzyme linked receptor protein signaling pathway | AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, SMAD3, SRC, TEK | 4.20894 |
[BP] GO:1903727 | positive regulation of phospholipid metabolic process | FABP3, FLT3, KIT, SRC, TEK | 4.20764 |
[BP] GO:0042592 | homeostatic process | ADORA1, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, EGFR, FABP3, FABP4, FLT3, GPR35, INSR, MET, SMAD3, SRC, TERT | 4.17673 |
[BP] GO:0051049 | regulation of transport | ABCB1, ACHE, ADORA1, ALOX15, APP, AXL, BCL2, CA2, CA7, CYP19A1, EGFR, GPR35, HCAR2, HSPA1A, INSR, MAOB, MMP9, PPARA, SMAD3, SRC, TERT | 4.14332 |
[BP] GO:0043393 | regulation of protein binding | APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT | 4.10497 |
[BP] GO:0048511 | rhythmic process | AXL, BCL2, CSNK2A1, DYRK1A, EGFR, KIT, PPARA, SRC, TOP1 | 4.09042 |
[BP] GO:0032844 | regulation of homeostatic process | ADORA1, AURKB, BCL2, CA2, CA7, EGFR, HCAR2, KDR, SRC, TNKS, TNKS2 | 4.05743 |
[BP] GO:0038083 | peptidyl-tyrosine autophosphorylation | EGFR, IGF1R, INSR, KDR, SRC | 4.03588 |
[BP] GO:0044267 | cellular protein metabolic process | ALPL, APP, AURKB, AXL, BACE1, BCL2, CSNK2A1, DUSP3, DYRK1A, EGFR, F10, FLT3, FUT7, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, NUAK1, PIM1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1 | 4.02343 |
[BP] GO:0010562 | positive regulation of phosphorus metabolic process | ADORA1, ALOX15, APP, BCL2, EGFR, FABP3, FLT3, INSR, KDR, KIT, MMP9, PDE5A, SMAD3, SRC, TEK, XDH | 4.02343 |
[BP] GO:0045937 | positive regulation of phosphate metabolic process | ADORA1, ALOX15, APP, BCL2, EGFR, FABP3, FLT3, INSR, KDR, KIT, MMP9, PDE5A, SMAD3, SRC, TEK, XDH | 4.02343 |
[BP] GO:0070482 | response to oxygen levels | ADORA1, BCL2, CYP1A1, MMP2, PPARA, SMAD3, SRC, TEK, TERT | 4.02343 |
[BP] GO:0051054 | positive regulation of DNA metabolic process | AURKB, DNMT1, EGFR, IGF1R, INSR, SRC, TNKS, TNKS2 | 4.00756 |
[BP] GO:0031325 | positive regulation of cellular metabolic process | ADORA1, ALOX15, APP, AURKB, BCL2, DNMT1, DYRK1A, EGFR, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MAOB, MET, MMP9, PDE5A, PPARA, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 3.98556 |
[BP] GO:0050790 | regulation of catalytic activity | ADORA1, ADORA3, APP, AURKB, BCL2, CSNK2A1, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KIT, MMP9, NUAK1, PDE5A, SMAD3, SRC, TEK, TERT, TNKS, XDH | 3.88608 |
[BP] GO:0009893 | positive regulation of metabolic process | ADORA1, ALOX15, APP, AURKB, BCL2, CSNK2A1, DNMT1, DYRK1A, EGFR, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MAOB, MET, MMP9, PDE5A, PPARA, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 3.88608 |
[BP] GO:0042493 | response to drug | ABCB1, AKR1B1, AXL, BCL2, CA9, CYP1A1, CYP1B1, EGFR, FABP3, KDR, MAOB, SRC, TOP1 | 3.84231 |
[BP] GO:0033559 | unsaturated fatty acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 | 3.82893 |
[BP] GO:0051247 | positive regulation of protein metabolic process | ADORA1, ALOX15, APP, BCL2, CSNK2A1, DNMT1, DYRK1A, EGFR, FLT3, HSPA1A, INSR, KDR, KIT, MMP9, PDE5A, SMAD3, SRC, TEK, XDH | 3.8063 |
[BP] GO:0051701 | interaction with host | AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC | 3.78792 |
[BP] GO:0019369 | arachidonic acid metabolic process | ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 | 3.78068 |
[BP] GO:0019538 | protein metabolic process | ACHE, ALPL, APP, AURKB, AXL, BACE1, BCL2, CSNK2A1, DUSP3, DYRK1A, EGFR, F10, FLT3, FUT7, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1 | 3.77581 |
[BP] GO:0007166 | cell surface receptor signaling pathway | ADORA1, ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 | 3.75645 |
[BP] GO:0008284 | positive regulation of cell proliferation | AKR1B1, BCL2, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MMP2, MMP9, PIM1, TEK, TERT | 3.75135 |
[BP] GO:1901615 | organic hydroxy compound metabolic process | AKR1B1, AKR1B10, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, MAOB, TYR | 3.75135 |
[BP] GO:0008210 | estrogen metabolic process | CYP19A1, CYP1B1, HSD17B1, HSD17B2 | 3.74568 |
[BP] GO:1903409 | reactive oxygen species biosynthetic process | CYP1A1, CYP1A2, CYP1B1, MAOB | 3.74568 |
[BP] GO:0072593 | reactive oxygen species metabolic process | BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR, MAOB | 3.74132 |
[BP] GO:0046686 | response to cadmium ion | CYP1A2, EGFR, KIT, MMP9, TERT | 3.73494 |
[BP] GO:0010243 | response to organonitrogen compound | AKR1B1, APP, DNMT1, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SRC, TEK, TYR | 3.73472 |
[BP] GO:0015711 | organic anion transport | ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA | 3.73472 |
[BP] GO:0048585 | negative regulation of response to stimulus | ADORA1, ALOX15, BCL2, CYP19A1, DUSP3, DYRK1A, EGFR, HSPA1A, IGF1R, MET, MMP9, PPARA, PTPRS, SMAD3, SRC, TEK, TERT, XDH | 3.73234 |
[BP] GO:0055114 | oxidation-reduction process | AKR1B1, AKR1B10, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2, MAOB, TYR, XDH | 3.71543 |
[BP] GO:0006690 | icosanoid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 | 3.71234 |
[BP] GO:0042325 | regulation of phosphorylation | ADORA1, ALOX15, APP, BCL2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, KIT, MMP9, PDE5A, PPARA, SRC, TEK, XDH | 3.66582 |
[BP] GO:0034754 | cellular hormone metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 | 3.63306 |
[BP] GO:0034614 | cellular response to reactive oxygen species | AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC | 3.63306 |
[BP] GO:0009987 | cellular process | ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, F10, FABP3, FABP4, FLT3, FUT7, GPR35, HCAR2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOB, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP1, TUBB3, TYR, XDH | 3.62128 |
[BP] GO:0007346 | regulation of mitotic cell cycle | APP, AURKB, BCL2, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TERT, TNKS | 3.62128 |
[BP] GO:0031401 | positive regulation of protein modification process | ADORA1, ALOX15, APP, BCL2, DNMT1, DYRK1A, EGFR, FLT3, INSR, KDR, KIT, MMP9, PDE5A, SRC, TEK, XDH | 3.6101 |
[BP] GO:0000302 | response to reactive oxygen species | AKR1B1, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC | 3.59526 |
[BP] GO:0032270 | positive regulation of cellular protein metabolic process | ADORA1, ALOX15, APP, BCL2, DNMT1, DYRK1A, EGFR, FLT3, HSPA1A, INSR, KDR, KIT, MMP9, PDE5A, SMAD3, SRC, TEK, XDH | 3.59081 |
[BP] GO:0043405 | regulation of MAP kinase activity | ADORA1, DUSP3, EGFR, FLT3, IGF1R, INSR, KIT, PDE5A, SRC | 3.58989 |
[BP] GO:0051240 | positive regulation of multicellular organismal process | APP, AXL, BCL2, CA2, CYP1B1, EGFR, HCAR2, HSPA1A, KDR, KIT, MET, MMP9, PDE5A, PIM1, SMAD3, SRC, TEK, TERT | 3.58391 |
[BP] GO:0050665 | hydrogen peroxide biosynthetic process | CYP1A1, CYP1A2, MAOB | 3.58365 |
[BP] GO:0006979 | response to oxidative stress | AKR1B1, APP, AXL, BCL2, CYP1B1, EGFR, HSPA1A, MMP9, SRC | 3.56635 |
[BP] GO:0001932 | regulation of protein phosphorylation | ADORA1, ALOX15, APP, BCL2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, KIT, MMP9, PDE5A, SRC, TEK, XDH | 3.56288 |
[BP] GO:0010604 | positive regulation of macromolecule metabolic process | ADORA1, ALOX15, APP, AURKB, BCL2, CSNK2A1, DNMT1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP9, PDE5A, PPARA, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 3.49514 |
[BP] GO:0001934 | positive regulation of protein phosphorylation | ADORA1, ALOX15, APP, BCL2, EGFR, FLT3, INSR, KDR, KIT, MMP9, PDE5A, SRC, TEK, XDH | 3.49313 |
[BP] GO:0051239 | regulation of multicellular organismal process | ADORA1, ADORA3, APP, AXL, BCL2, CA2, CYP1B1, EGFR, GPR35, HCAR2, HSPA1A, INSR, KDR, KIT, MET, MMP9, PDE5A, PIM1, PTPRS, SMAD3, SRC, TEK, TERT, TNKS2, XDH | 3.48276 |
[BP] GO:0042445 | hormone metabolic process | ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 | 3.45049 |
[BP] GO:0044093 | positive regulation of molecular function | ABCB1, ADORA1, APP, AURKB, BCL2, EGFR, FLT3, HSPA1A, INSR, KIT, MET, MMP9, PDE5A, SMAD3, SRC, TEK, TERT, TNKS, XDH | 3.45049 |
[BP] GO:1901698 | response to nitrogen compound | AKR1B1, APP, DNMT1, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SRC, TEK, TYR | 3.44681 |
[BP] GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | FLT3, KIT, SRC, TEK | 3.44074 |
[BP] GO:0042743 | hydrogen peroxide metabolic process | CYP1A1, CYP1A2, EGFR, MAOB | 3.44074 |
[BP] GO:0051050 | positive regulation of transport | ABCB1, ACHE, ADORA1, APP, AXL, BCL2, CA2, CYP19A1, EGFR, HCAR2, INSR, SMAD3, SRC, TERT | 3.42544 |
[BP] GO:0019216 | regulation of lipid metabolic process | ADORA1, CYP1A1, FABP3, FLT3, HCAR2, KIT, PPARA, SRC, TEK | 3.39732 |
[BP] GO:0006464 | cellular protein modification process | ALPL, APP, AURKB, AXL, BCL2, CSNK2A1, DUSP3, DYRK1A, EGFR, F10, FLT3, FUT7, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1 | 3.3927 |
[BP] GO:0036211 | protein modification process | ALPL, APP, AURKB, AXL, BCL2, CSNK2A1, DUSP3, DYRK1A, EGFR, F10, FLT3, FUT7, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1 | 3.3927 |
[BP] GO:0045834 | positive regulation of lipid metabolic process | FABP3, FLT3, KIT, PPARA, SRC, TEK | 3.37491 |
[BP] GO:0051128 | regulation of cellular component organization | ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, DNMT1, EGFR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP9, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2 | 3.35318 |
[BP] GO:0034599 | cellular response to oxidative stress | AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC | 3.34114 |
[BP] GO:0010648 | negative regulation of cell communication | ACHE, ADORA1, BCL2, DUSP3, DYRK1A, EGFR, GPR35, HSPA1A, IGF1R, MET, MMP9, PTPRS, SMAD3, SRC, TERT, XDH | 3.3409 |
[BP] GO:0023057 | negative regulation of signaling | ACHE, ADORA1, BCL2, DUSP3, DYRK1A, EGFR, GPR35, HSPA1A, IGF1R, MET, MMP9, PTPRS, SMAD3, SRC, TERT, XDH | 3.32587 |
[BP] GO:0042327 | positive regulation of phosphorylation | ADORA1, ALOX15, APP, BCL2, EGFR, FLT3, INSR, KDR, KIT, MMP9, PDE5A, SRC, TEK, XDH | 3.31509 |
[BP] GO:2001225 | regulation of chloride transport | ABCB1, CA2, CA7 | 3.31499 |
[BP] GO:0097267 | omega-hydroxylase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 3.31499 |
[BP] GO:1903725 | regulation of phospholipid metabolic process | FABP3, FLT3, KIT, SRC, TEK | 3.31254 |
[BP] GO:0090218 | positive regulation of lipid kinase activity | FLT3, KIT, SRC, TEK | 3.30469 |
[BP] GO:0048661 | positive regulation of smooth muscle cell proliferation | AKR1B1, EGFR, MMP2, MMP9, TERT | 3.20299 |
[BP] GO:0051338 | regulation of transferase activity | ADORA1, APP, AURKB, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KIT, PDE5A, SRC, TEK, TNKS | 3.20127 |
[BP] GO:0044092 | negative regulation of molecular function | ADORA3, APP, AURKB, CSNK2A1, CYP1B1, DUSP3, FABP4, GPR35, IGF1R, MET, MMP9, PIM1, PPARA, SRC, TNKS | 3.19395 |
[BP] GO:0002320 | lymphoid progenitor cell differentiation | BCL2, FLT3, KIT | 3.19321 |
[BP] GO:0006631 | fatty acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA | 3.15135 |
[BP] GO:0010817 | regulation of hormone levels | ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, EGFR, HCAR2, HSD17B1, HSD17B2 | 3.11164 |
[BP] GO:0050804 | modulation of chemical synaptic transmission | ACHE, ADORA1, APP, BACE1, CA2, CA7, EGFR, KIT | 3.10458 |
[BP] GO:0099177 | regulation of trans-synaptic signaling | ACHE, ADORA1, APP, BACE1, CA2, CA7, EGFR, KIT | 3.10458 |
[BP] GO:0009636 | response to toxic substance | AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, KDR, MAOB, SRC | 3.09257 |
[BP] GO:0043412 | macromolecule modification | ALPL, APP, AURKB, AXL, BCL2, CSNK2A1, DNMT1, DUSP3, DYRK1A, EGFR, F10, FLT3, FUT7, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1 | 3.04241 |
[BP] GO:0048545 | response to steroid hormone | ALPL, BCL2, CA2, EGFR, FLT3, MAOB, SRC | 3.03965 |
[BP] GO:0080135 | regulation of cellular response to stress | APP, DUSP3, DYRK1A, EGFR, HSPA1A, IGF1R, MET, NUAK1, PTPRS, TERT, XDH | 2.99008 |
[BP] GO:0017144 | drug metabolic process | ACHE, AKR1B1, AKR1B10, CBR1, CYP1A1, CYP1A2, CYP1B1, EGFR, HSPA1A, MAOB | 2.98952 |
[BP] GO:0006703 | estrogen biosynthetic process | CYP19A1, HSD17B1, HSD17B2 | 2.98192 |
[BP] GO:0071248 | cellular response to metal ion | ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 | 2.97727 |
[BP] GO:0032846 | positive regulation of homeostatic process | AURKB, CA2, CA7, EGFR, HCAR2, TNKS, TNKS2 | 2.96708 |
[BP] GO:0032268 | regulation of cellular protein metabolic process | ADORA1, ALOX15, APP, BCL2, CSNK2A1, DNMT1, DUSP3, DYRK1A, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MMP9, NUAK1, PDE5A, SMAD3, SRC, TEK, XDH | 2.93846 |
[BP] GO:0001101 | response to acid chemical | AKR1B1, DNMT1, EGFR, FABP3, HSD17B2, KDR, MMP2, SRC | 2.91833 |
[BP] GO:0043551 | regulation of phosphatidylinositol 3-kinase activity | FLT3, KIT, SRC, TEK | 2.88907 |
[BP] GO:0006820 | anion transport | ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA | 2.88907 |
[BP] GO:0030155 | regulation of cell adhesion | ALOX15, BCL2, CYP1B1, DUSP3, KDR, NUAK1, PDE5A, PPARA, SMAD3, SRC, TEK | 2.88907 |
[BP] GO:0048878 | chemical homeostasis | AKR1B1, APP, BCL2, CA12, CA2, CA7, EGFR, FABP3, FABP4, GPR35, INSR, MET, SMAD3 | 2.88381 |
[BP] GO:0031960 | response to corticosteroid | ALPL, BCL2, EGFR, FLT3, MAOB, SRC | 2.88058 |
[BP] GO:1901568 | fatty acid derivative metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 | 2.88058 |
[BP] GO:0043085 | positive regulation of catalytic activity | ADORA1, APP, AURKB, BCL2, EGFR, FLT3, HSPA1A, INSR, KIT, PDE5A, SMAD3, SRC, TEK, TERT, TNKS, XDH | 2.85603 |
[BP] GO:0071495 | cellular response to endogenous stimulus | AKR1B1, APP, DNMT1, EGFR, FLT3, IGF1R, INSR, KIT, MMP2, SMAD3, SRC | 2.81706 |
[BP] GO:0070198 | None | TERT, TNKS, TNKS2 | 2.81377 |
[BP] GO:0048732 | gland development | BCL2, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR | 2.80041 |
[BP] GO:0006950 | response to stress | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, HSPA1A, KIT, MMP2, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, TERT | 2.80041 |
[BP] GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling | EGFR, FLT3, KDR, KIT, TEK | 2.75498 |
[BP] GO:0019222 | regulation of metabolic process | ACHE, ADORA1, ADORA3, ALOX15, APP, AURKB, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, FABP3, FABP4, FLT3, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOB, MET, MMP9, NUAK1, PDE5A, PIM1, PPARA, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP1, XDH | 2.75147 |
[BP] GO:0018105 | peptidyl-serine phosphorylation | AURKB, BCL2, DYRK1A, SRC, TNKS, TOP1 | 2.74724 |
[BP] GO:0048534 | hematopoietic or lymphoid organ development | BCL2, FLT3, KDR, KIT, TEK, TYR | 2.71982 |
[BP] GO:0008285 | negative regulation of cell proliferation | ADORA1, ADORA3, APP, BCL2, CYP1B1, FABP3, HSPA1A, PDE5A, SMAD3, TERT, XDH | 2.71982 |
[BP] GO:1901652 | response to peptide | AKR1B1, APP, FABP3, IGF1R, INSR, PPARA, SRC, TEK | 2.70647 |
[BP] GO:0001676 | long-chain fatty acid metabolic process | ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 | 2.70554 |
[BP] GO:2000377 | regulation of reactive oxygen species metabolic process | BCL2, CYP1B1, EGFR, INSR, SMAD3, XDH | 2.69937 |
[BP] GO:0051828 | entry into other organism involved in symbiotic interaction | AXL, EGFR, HSPA1A, MET, SRC | 2.69357 |
[BP] GO:0051806 | entry into cell of other organism involved in symbiotic interaction | AXL, EGFR, HSPA1A, MET, SRC | 2.69357 |
[BP] GO:0030260 | entry into host cell | AXL, EGFR, HSPA1A, MET, SRC | 2.69357 |
[BP] GO:0044409 | entry into host | AXL, EGFR, HSPA1A, MET, SRC | 2.69357 |
[BP] GO:0043549 | regulation of kinase activity | ADORA1, APP, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KIT, PDE5A, SRC, TEK | 2.68896 |
[BP] GO:1904355 | positive regulation of telomere capping | AURKB, TNKS, TNKS2 | 2.67613 |
[BP] GO:0071241 | cellular response to inorganic substance | ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 | 2.66867 |
[BP] GO:0001952 | regulation of cell-matrix adhesion | BCL2, KDR, SMAD3, SRC, TEK | 2.65941 |
[BP] GO:0051726 | regulation of cell cycle | APP, AURKB, BCL2, CSNK2A1, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, SRC, TERT, TNKS | 2.6207 |
[BP] GO:0043550 | regulation of lipid kinase activity | FLT3, KIT, SRC, TEK | 2.61456 |
[BP] GO:0009895 | negative regulation of catabolic process | ADORA1, BCL2, EGFR, HCAR2, MET, PPARA, SMAD3 | 2.61133 |
[BP] GO:0043406 | positive regulation of MAP kinase activity | ADORA1, EGFR, FLT3, INSR, KIT, PDE5A, SRC | 2.60252 |
[BP] GO:1901654 | None | AKR1B1, CA9, CSNK2A1, EGFR, MAOB, SRC | 2.59693 |
[BP] GO:0006721 | terpenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR | 2.59184 |
[BP] GO:0032210 | regulation of telomere maintenance via telomerase | AURKB, SRC, TNKS, TNKS2 | 2.59184 |
[BP] GO:0065007 | biological regulation | ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, F10, FABP3, FABP4, FLT3, GPR35, HCAR2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOB, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP1, XDH | 2.59122 |
[BP] GO:0042542 | response to hydrogen peroxide | AKR1B1, AXL, BCL2, CYP1B1, SRC | 2.57885 |
[BP] GO:0051893 | regulation of focal adhesion assembly | KDR, SMAD3, SRC, TEK | 2.56787 |
[BP] GO:0090109 | regulation of cell-substrate junction assembly | KDR, SMAD3, SRC, TEK | 2.56787 |
[BP] GO:0045787 | positive regulation of cell cycle | APP, AURKB, CYP1A1, DUSP3, EGFR, INSR, SRC, TERT | 2.56032 |
[BP] GO:0032849 | positive regulation of cellular pH reduction | CA2, CA7 | 2.56032 |
[BP] GO:0048608 | reproductive structure development | AXL, BCL2, CYP19A1, HSD17B2, INSR, KIT, SRC | 2.56032 |
[BP] GO:0016042 | lipid catabolic process | ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 | 2.56032 |
[BP] GO:0051900 | regulation of mitochondrial depolarization | BCL2, KDR, SRC | 2.55822 |
[BP] GO:0044089 | positive regulation of cellular component biogenesis | ALOX15, HSPA1A, KDR, KIT, MET, MMP1, SMAD3, SRC, TEK | 2.55442 |
[BP] GO:0002682 | regulation of immune system process | ADORA1, ALOX15, APP, AXL, BCL2, CA2, CYP19A1, DUSP3, HCAR2, HSPA1A, KIT, MMP2, PDE5A, PTPRS, SMAD3, SRC | 2.54564 |
[BP] GO:0018209 | peptidyl-serine modification | AURKB, BCL2, DYRK1A, SRC, TNKS, TOP1 | 2.54097 |
[BP] GO:0070372 | regulation of ERK1 and ERK2 cascade | ALOX15, APP, DUSP3, EGFR, KDR, SRC, TEK | 2.52778 |
[BP] GO:0044419 | interspecies interaction between organisms | AXL, DYRK1A, EGFR, HSPA1A, INSR, KDR, MET, MMP1, SMAD3, SRC, TOP1 | 2.50801 |
[BP] GO:1901701 | cellular response to oxygen-containing compound | AKR1B1, APP, AXL, CYP1B1, DNMT1, EGFR, IGF1R, INSR, MMP2, MMP9, SRC | 2.50436 |
[BP] GO:0010810 | regulation of cell-substrate adhesion | ALOX15, BCL2, KDR, SMAD3, SRC, TEK | 2.49719 |
[BP] GO:1903391 | regulation of adherens junction organization | KDR, SMAD3, SRC, TEK | 2.49719 |
[BP] GO:0033043 | regulation of organelle organization | ALOX15, AURKB, BCL2, DNMT1, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 | 2.49657 |
[BP] GO:0050728 | negative regulation of inflammatory response | ADORA1, CYP19A1, PPARA, SMAD3, TEK | 2.47689 |
[BP] GO:1901575 | None | ACHE, ADORA1, AKR1B10, AURKB, BACE1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, HSPA1A, MAOB, PDE5A, XDH | 2.47266 |
[BP] GO:0002009 | morphogenesis of an epithelium | BCL2, CA2, CA9, EGFR, MET, SMAD3, SRC | 2.46266 |
[BP] GO:0071900 | regulation of protein serine/threonine kinase activity | ADORA1, DUSP3, EGFR, FLT3, IGF1R, INSR, KIT, PDE5A, SRC | 2.45896 |
[BP] GO:0080090 | regulation of primary metabolic process | ADORA1, ADORA3, ALOX15, APP, AURKB, BCL2, CA9, CSNK2A1, CYP1A1, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, FABP3, FABP4, FLT3, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOB, MET, MMP9, NUAK1, PDE5A, PIM1, PPARA, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 2.45802 |
[BP] GO:0051052 | regulation of DNA metabolic process | AURKB, DNMT1, EGFR, IGF1R, INSR, SRC, TNKS, TNKS2 | 2.45292 |
[BP] GO:0034502 | protein localization to chromosome | AURKB, TERT, TNKS, TNKS2 | 2.45111 |
[BP] GO:0019373 | epoxygenase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 2.45111 |
[BP] GO:1904356 | regulation of telomere maintenance via telomere lengthening | AURKB, SRC, TNKS, TNKS2 | 2.42445 |
[BP] GO:0071417 | cellular response to organonitrogen compound | AKR1B1, APP, DNMT1, EGFR, IGF1R, INSR, MMP2, SRC | 2.40586 |
[BP] GO:0070374 | positive regulation of ERK1 and ERK2 cascade | ALOX15, APP, EGFR, KDR, SRC, TEK | 2.405 |
[BP] GO:0042446 | hormone biosynthetic process | AKR1B1, CYP19A1, HSD17B1, HSD17B2 | 2.40212 |
[BP] GO:1904707 | positive regulation of vascular smooth muscle cell proliferation | MMP2, MMP9, TERT | 2.39753 |
[BP] GO:0050806 | positive regulation of synaptic transmission | ADORA1, APP, CA2, CA7, EGFR | 2.3926 |
[BP] GO:1902532 | negative regulation of intracellular signal transduction | BCL2, DUSP3, DYRK1A, HSPA1A, IGF1R, MET, MMP9, SRC, XDH | 2.385 |
[BP] GO:0031347 | regulation of defense response | ADORA1, CYP19A1, EGFR, FABP4, HSPA1A, MMP2, PPARA, PTPRS, SMAD3, SRC, TEK | 2.36478 |
[BP] GO:0045859 | regulation of protein kinase activity | ADORA1, APP, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KIT, PDE5A, SRC | 2.35781 |
[BP] GO:0046486 | glycerolipid metabolic process | ACHE, ALOX15, CSNK2A1, EGFR, FABP3, FABP4, KIT, MET | 2.35348 |
[BP] GO:0009404 | toxin metabolic process | CYP1A1, CYP1A2, CYP1B1 | 2.35111 |
[BP] GO:0040008 | regulation of growth | APP, BCL2, CSNK2A1, EGFR, HSPA1A, INSR, PIM1, PTPRS, SMAD3, TNKS2 | 2.35094 |
[BP] GO:0006720 | isoprenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR | 2.34278 |
[BP] GO:0010634 | positive regulation of epithelial cell migration | KDR, MET, MMP9, SRC, TEK | 2.34278 |
[BP] GO:2000573 | positive regulation of DNA biosynthetic process | AURKB, SRC, TNKS, TNKS2 | 2.34182 |
[BP] GO:0051094 | positive regulation of developmental process | APP, AXL, BCL2, CA2, CYP1B1, INSR, KDR, KIT, PDE5A, PIM1, SMAD3, SRC, TEK, TERT | 2.33383 |
[BP] GO:0070213 | None | TNKS, TNKS2 | 2.32961 |
[BP] GO:0018894 | dibenzo-p-dioxin metabolic process | CYP1A1, CYP1A2 | 2.32961 |
[BP] GO:0051246 | regulation of protein metabolic process | ADORA1, ALOX15, APP, BCL2, CSNK2A1, DNMT1, DUSP3, DYRK1A, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MMP9, NUAK1, PDE5A, SMAD3, SRC, TEK, XDH | 2.32961 |
[BP] GO:0009892 | negative regulation of metabolic process | ADORA1, APP, AURKB, BCL2, CSNK2A1, DNMT1, DUSP3, DYRK1A, EGFR, FABP4, HCAR2, HSPA1A, IGF1R, KDR, MET, MMP9, PPARA, SMAD3, SRC, TERT, TNKS, TNKS2, XDH | 2.322 |
[BP] GO:0051894 | None | KDR, SMAD3, TEK | 2.31119 |
[BP] GO:2000021 | regulation of ion homeostasis | ADORA1, BCL2, CA2, CA7, KDR, SRC | 2.30924 |
[BP] GO:0048660 | regulation of smooth muscle cell proliferation | AKR1B1, EGFR, MMP2, MMP9, TERT | 2.30924 |
[BP] GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling | FLT3, KDR, KIT, TEK | 2.30466 |
[BP] GO:0007165 | signal transduction | ADORA1, ADORA3, AKR1B1, APP, AXL, BCL2, CA1, CA2, CSNK2A1, CYP1B1, DNMT1, EGFR, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2 | 2.28412 |
[BP] GO:0001775 | cell activation | ALOX5, APP, AXL, BCL2, EGFR, FLT3, FUT7, HSPA1A, KIT, MMP9, SMAD3, SRC | 2.28412 |
[BP] GO:1900182 | positive regulation of protein localization to nucleus | APP, EGFR, SMAD3, SRC, TERT | 2.28412 |
[BP] GO:0006807 | nitrogen compound metabolic process | ACHE, AKR1B1, AKR1B10, ALPL, APP, AURKB, AXL, BACE1, BCL2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, F10, FLT3, FUT7, HSPA1A, IGF1R, INSR, KDR, KIT, MAOB, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP1, TYR, XDH | 2.26486 |
[BP] GO:1904353 | regulation of telomere capping | AURKB, TNKS, TNKS2 | 2.22358 |
[BP] GO:1903393 | None | KDR, SMAD3, TEK | 2.22358 |
[BP] GO:1901699 | cellular response to nitrogen compound | AKR1B1, APP, DNMT1, EGFR, IGF1R, INSR, MMP2, SRC | 2.21765 |
[BP] GO:0051347 | positive regulation of transferase activity | ADORA1, AURKB, EGFR, FLT3, INSR, KIT, PDE5A, SRC, TEK, TNKS | 2.21594 |
[BP] GO:0048869 | cellular developmental process | ACHE, ALPL, APP, AXL, BCL2, CBR1, CYP1A1, EGFR, FABP4, FLT3, FUT7, KDR, KIT, MET, MMP2, MMP9, PTPRS, SMAD3, SRC, TEK, TERT | 2.20834 |
[BP] GO:0031099 | regeneration | AXL, BCL2, CSNK2A1, EGFR, FLT3 | 2.20473 |
[BP] GO:1904357 | None | SRC, TNKS, TNKS2 | 2.18009 |
[BP] GO:0050793 | regulation of developmental process | APP, AXL, BCL2, CA2, CYP1B1, EGFR, INSR, KDR, KIT, NUAK1, PDE5A, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TERT, TNKS2, XDH | 2.17873 |
[BP] GO:0051384 | response to glucocorticoid | ALPL, BCL2, EGFR, FLT3, MAOB | 2.16524 |
[BP] GO:0002318 | myeloid progenitor cell differentiation | FLT3, KIT | 2.14394 |
[BP] GO:0043271 | negative regulation of ion transport | ADORA1, BCL2, GPR35, MAOB, MMP9 | 2.13989 |
[BP] GO:0007155 | cell adhesion | ACHE, APP, AXL, BCL2, CYP1B1, EGFR, KIT, NUAK1, PTPRS, SRC, TEK | 2.11592 |
[BP] GO:0045931 | positive regulation of mitotic cell cycle | APP, CYP1A1, DUSP3, INSR, TERT | 2.10073 |
[BP] GO:0032845 | None | ADORA1, BCL2, SRC, TNKS, TNKS2 | 2.10073 |
[BP] GO:0031100 | animal organ regeneration | AXL, CSNK2A1, EGFR, FLT3 | 2.09949 |
[BP] GO:0050730 | None | ADORA1, APP, EGFR, FLT3, KIT, SRC | 2.09818 |
[BP] GO:0022610 | biological adhesion | ACHE, APP, AXL, BCL2, CYP1B1, EGFR, KIT, NUAK1, PTPRS, SRC, TEK | 2.09676 |
[BP] GO:0042060 | None | ALOX15, EGFR, PPARA, SMAD3 | 2.08247 |
[BP] GO:0046427 | positive regulation of JAK-STAT cascade | AKR1B1, CYP1B1, FLT3, KIT | 2.08247 |
[BP] GO:0010564 | regulation of cell cycle process | APP, AURKB, BCL2, CSNK2A1, CYP1A1, EGFR, HSPA1A, INSR, TERT, TNKS | 2.06783 |
[BP] GO:0018107 | peptidyl-threonine phosphorylation | BCL2, CSNK2A1, DYRK1A, TNKS | 2.06675 |
[BP] GO:0032204 | None | AURKB, SRC, TNKS, TNKS2 | 2.06675 |
[BP] GO:0018958 | None | AKR1B1, BCL2, MAOB, TYR | 2.06675 |
[BP] GO:0009968 | negative regulation of signal transduction | BCL2, DUSP3, DYRK1A, EGFR, HSPA1A, IGF1R, MET, MMP9, PTPRS, SMAD3, SRC, TERT, XDH | 2.06675 |
[BP] GO:0022414 | reproductive process | AKR1B1, ALPL, APP, AXL, BCL2, CYP19A1, CYP1A1, EGFR, HSD17B2, INSR, KIT, MMP2, MMP9, SRC | 2.06248 |
[BP] GO:1904894 | positive regulation of STAT cascade | AKR1B1, CYP1B1, FLT3, KIT | 2.04793 |
[BP] GO:0060255 | regulation of macromolecule metabolic process | ACHE, ADORA1, ADORA3, ALOX15, APP, AURKB, BCL2, CA9, CSNK2A1, CYP1A2, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP9, NUAK1, PDE5A, PIM1, PPARA, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP1, XDH | 2.03561 |
[BP] GO:1901890 | None | KDR, SMAD3, TEK | 2.03117 |
[BP] GO:0071276 | cellular response to cadmium ion | CYP1A2, EGFR, MMP9 | 2.03117 |
[BP] GO:2000352 | None | KDR, TEK, TERT | 2.03117 |
[BP] GO:0031323 | regulation of cellular metabolic process | ACHE, ADORA1, ADORA3, ALOX15, APP, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MAOB, MET, MMP9, NUAK1, PDE5A, PIM1, PPARA, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH | 2.01204 |
[BP] GO:0051902 | negative regulation of mitochondrial depolarization | BCL2, SRC | 2.00355 |
[BP] GO:1990535 | None | APP, INSR | 2.00355 |
[BP] GO:2001300 | lipoxin metabolic process | ALOX15, ALOX5 | 2.00355 |
[BP] GO:0044070 | regulation of anion transport | ABCB1, ADORA1, CA2, CA7 | 2.00211 |
[BP] GO:0033273 | response to vitamin | ALPL, CYP1A1, EGFR, TYR | 2.00211 |
[BP] GO:1901888 | regulation of cell junction assembly | KDR, SMAD3, SRC, TEK | 2.00211 |
[BP] GO:0032228 | regulation of synaptic transmission, GABAergic | ADORA1, CA2, CA7 | 2.00197 |
[CC] GO:0005886 | plasma membrane | ABCB1, ACHE, ADORA1, ADORA3, ALOX15, ALPL, APP, AXL, BACE1, CA12, CA14, CA2, CA4, CA9, CSNK2A1, EGFR, F10, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, MMP2, PIM1, PTPRS, SMAD3, SRC, TEK, TERT | 3.3683 |
[CC] GO:0044459 | plasma membrane part | ABCB1, ADORA1, ADORA3, ALOX15, APP, AXL, BACE1, CA2, CA4, CA9, DUSP3, EGFR, F10, FLT3, GPR35, IGF1R, INSR, KDR, KIT, MET, PTPRS, SRC, TEK | 2.98192 |
[CC] GO:0016020 | membrane | ABCB1, ACHE, ADORA1, ADORA3, ALOX15, ALOX5, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, F10, FLT3, FUT7, GPR35, HCAR2, HSD17B2, IGF1R, INSR, KDR, KIT, MAOB, MET, MMP2, PIM1, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TYR | 2.98192 |
[CC] GO:0016323 | basolateral plasma membrane | ADORA1, CA2, CA4, CA9, EGFR, TEK | 2.51788 |
[CC] GO:0045121 | membrane raft | APP, BACE1, EGFR, INSR, KDR, SRC, TEK | 2.37999 |
[CC] GO:0098857 | membrane microdomain | APP, BACE1, EGFR, INSR, KDR, SRC, TEK | 2.36466 |
[CC] GO:0009986 | cell surface | ABCB1, ACHE, APP, AXL, BACE1, CA4, EGFR, MET, TEK | 2.26727 |
[CC] GO:0031226 | intrinsic component of plasma membrane | ADORA1, ADORA3, APP, AXL, BACE1, CA4, F10, FLT3, GPR35, IGF1R, INSR, KDR, MET, PTPRS, TEK | 2.23861 |
[CC] GO:0043227 | membrane-bounded organelle | ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA4, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, FABP3, FABP4, FLT3, FUT7, HSPA1A, IGF1R, INSR, KDR, KIT, MAOB, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPRS, SMAD3, SRC, TERT, TNKS, TNKS2, TOP1, TUBB3, TYR, XDH | 2.22756 |
[CC] GO:0044444 | cytoplasmic part | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, AURKB, BACE1, BCL2, CA1, CA2, CA4, CA7, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, F10, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, KIT, MAOB, MMP2, MMP9, PDE5A, PIM1, PTPRS, SMAD3, SRC, TERT, TNKS, TNKS2, TOP1, TYR, XDH | 2.03117 |
[MF] GO:0003824 | catalytic activity | ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AURKB, AXL, BACE1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, F10, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOB, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PIM1, PTPRS, SRC, TEK, TERT, TNKS, TNKS2, TOP1, TUBB3, TYR, XDH | 15.3515 |
[MF] GO:0043167 | ion binding | ABCB1, ACHE, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, EGFR, F10, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MAOB, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, TOP1, TUBB3, TYR, XDH | 11.7389 |
[MF] GO:0004089 | carbonate dehydratase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 10.0525 |
[MF] GO:0046914 | transition metal ion binding | ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, MMP1, MMP2, MMP9, PIM1, PPARA, SMAD3, TNKS, TYR, XDH | 9.34772 |
[MF] GO:0004714 | transmembrane receptor protein tyrosine kinase activity | AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, TEK | 9.03696 |
[MF] GO:0019199 | transmembrane receptor protein kinase activity | AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, TEK | 8.21483 |
[MF] GO:0004713 | protein tyrosine kinase activity | AXL, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK | 7.7244 |
[MF] GO:0004672 | protein kinase activity | AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, TOP1 | 6.76842 |
[MF] GO:0016836 | hydro-lyase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 6.59775 |
[MF] GO:0008144 | drug binding | ABCB1, ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PPARA, SRC, TEK, TOP1 | 6.59652 |
[MF] GO:0043168 | anion binding | ABCB1, ALOX15, APP, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, F10, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MAOB, MET, NUAK1, PDE5A, PIM1, PTPRS, SRC, TEK, TOP1, TUBB3, XDH | 6.03291 |
[MF] GO:0016773 | phosphotransferase activity, alcohol group as acceptor | AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, TOP1 | 5.78786 |
[MF] GO:0036094 | small molecule binding | ABCB1, ADORA1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MAOB, MET, NUAK1, PDE5A, PIM1, SRC, TEK, TOP1, TUBB3, XDH | 5.76675 |
[MF] GO:0016835 | carbon-oxygen lyase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 5.73035 |
[MF] GO:0004716 | signal transducer, downstream of receptor, with protein tyrosine kinase activity | EGFR, INSR, KDR, KIT | 5.38069 |
[MF] GO:0016301 | kinase activity | AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, TOP1 | 5.32254 |
[MF] GO:0016772 | transferase activity, transferring phosphorus-containing groups | AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, TERT, TOP1 | 5.15228 |
[MF] GO:0000166 | nucleotide binding | ABCB1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MAOB, MET, NUAK1, PDE5A, PIM1, SRC, TEK, TOP1, TUBB3, XDH | 5.09518 |
[MF] GO:1901265 | nucleoside phosphate binding | ABCB1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MAOB, MET, NUAK1, PDE5A, PIM1, SRC, TEK, TOP1, TUBB3, XDH | 5.09518 |
[MF] GO:0016491 | oxidoreductase activity | AKR1B1, AKR1B10, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2, MAOB, TYR, XDH | 4.60576 |
[MF] GO:0097367 | carbohydrate derivative binding | ABCB1, ADORA1, APP, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PDE5A, PIM1, PTPRS, SRC, TEK, TOP1, TUBB3 | 4.27066 |
[MF] GO:0043169 | cation binding | ACHE, ALOX15, ALOX5, ALPL, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, F10, KIT, MMP1, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, SMAD3, TERT, TNKS, TNKS2, TYR, XDH | 4.14922 |
[MF] GO:0046872 | metal ion binding | ALOX15, ALOX5, ALPL, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, F10, KIT, MMP1, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, SMAD3, TERT, TNKS, TNKS2, TYR, XDH | 3.89605 |
[MF] GO:0070330 | aromatase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 3.79228 |
[MF] GO:0005506 | iron ion binding | ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH | 3.76084 |
[MF] GO:0005524 | ATP binding | ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, TOP1 | 3.75645 |
[MF] GO:0140096 | catalytic activity, acting on a protein | AURKB, AXL, BACE1, CSNK2A1, DUSP3, DYRK1A, EGFR, F10, FLT3, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PTPRS, SRC, TEK, TOP1 | 3.73795 |
[MF] GO:0032559 | adenyl ribonucleotide binding | ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, TOP1 | 3.65211 |
[MF] GO:0032555 | purine ribonucleotide binding | ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PDE5A, PIM1, SRC, TEK, TOP1, TUBB3 | 3.6346 |
[MF] GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 3.6346 |
[MF] GO:0030554 | adenyl nucleotide binding | ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, TOP1 | 3.62494 |
[MF] GO:0017076 | purine nucleotide binding | ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PDE5A, PIM1, SRC, TEK, TOP1, TUBB3 | 3.6101 |
[MF] GO:0032553 | ribonucleotide binding | ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PDE5A, PIM1, SRC, TEK, TOP1, TUBB3 | 3.60191 |
[MF] GO:0008270 | zinc ion binding | CA1, CA12, CA2, CA4, CA7, CA9, DNMT1, MMP1, MMP2, MMP9, PPARA, SMAD3, TNKS | 3.49279 |
[MF] GO:0016829 | lyase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 3.46209 |
[MF] GO:0035639 | purine ribonucleoside triphosphate binding | ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, TOP1, TUBB3 | 3.26105 |
[MF] GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | AKR1B1, AKR1B10, CBR1, HSD17B1, HSD17B2, XDH | 3.1587 |
[MF] GO:0042562 | hormone binding | ACHE, EGFR, HSD17B1, IGF1R, INSR | 2.99008 |
[MF] GO:0019825 | oxygen binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 2.82068 |
[MF] GO:0004497 | monooxygenase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR | 2.79707 |
[MF] GO:0042802 | identical protein binding | ACHE, APP, BCL2, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, KDR, KIT, MAOB, MET, MMP9, SMAD3, TERT, TYR, XDH | 2.75001 |
[MF] GO:0044877 | macromolecular complex binding | ACHE, ADORA1, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MMP9, PIM1, PPARA, SMAD3, SRC | 2.71004 |
[MF] GO:0016740 | transferase activity | AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, EGFR, FLT3, FUT7, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, TERT, TNKS, TNKS2, TOP1 | 2.6125 |
[MF] GO:0009055 | electron transfer activity | AKR1B1, CYP19A1, CYP1A2, MAOB, XDH | 2.57885 |
[MF] GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | AKR1B1, AKR1B10, CBR1, HSD17B1, HSD17B2 | 2.41967 |
[MF] GO:0005057 | signal transducer activity, downstream of receptor | EGFR, INSR, KDR, KIT, SMAD3 | 2.37999 |
[MF] GO:0032403 | protein complex binding | ACHE, ADORA1, EGFR, FLT3, IGF1R, INSR, KDR, MMP9, PPARA, SMAD3, SRC | 2.3439 |
[MF] GO:0051425 | None | APP, INSR | 2.32961 |
[MF] GO:0020037 | heme binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC | 2.30924 |
[MF] GO:0019838 | growth factor binding | EGFR, IGF1R, INSR, KDR, TEK | 2.28412 |
[MF] GO:0046906 | tetrapyrrole binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC | 2.17873 |
[MF] GO:0043559 | insulin binding | IGF1R, INSR | 2.14394 |
[MF] GO:0043548 | phosphatidylinositol 3-kinase binding | AXL, IGF1R, INSR | 2.09949 |
[MF] GO:0038023 | signaling receptor activity | ADORA1, ADORA3, AXL, EGFR, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, PPARA, TEK | 2.01425 |
[MF] GO:0004064 | arylesterase activity | CA1, CA2 | 2.00355 |
KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
---|---|---|
Ovarian steroidogenesis_Homo sapiens_hsa04913 | ALOX5, INSR, HSD17B1, HSD17B2, CYP1A1, CYP1B1, CYP19A1, IGF1R | 9.5375 |
Nitrogen metabolism_Homo sapiens_hsa00910 | CA12, CA1, CA2, CA4, CA7, CA9, CA14 | 11.1048 |
Adherens junction_Homo sapiens_hsa04520 | SMAD3, CSNK2A1, SRC, INSR, MET, EGFR, IGF1R | 6.6786 |
Steroid hormone biosynthesis_Homo sapiens_hsa00140 | HSD17B1, HSD17B2, CYP1A2, CYP1A1, CYP1B1, CYP19A1 | 5.9045 |
Pathways in cancer_Homo sapiens_hsa05200 | SMAD3, FLT3, MMP1, MMP2, KIT, BCL2, MMP9, MET, EGFR, IGF1R | 4.9073 |
Rap1 signaling pathway_Homo sapiens_hsa04015 | SRC, INSR, KIT, KDR, TEK, MET, EGFR, IGF1R | 4.9918 |
Bladder cancer_Homo sapiens_hsa05219 | SRC, MMP1, MMP2, MMP9, EGFR | 5.1932 |
Metabolic pathways_Homo sapiens_hsa01100 | CBR1, DNMT1, MAOB, ALOX15, AKR1B1, TYR, CYP19A1, FUT7, AKR1B10, ALOX5, HSD17B1, HSD17B2, CYP1A2, CYP1A1, ALPL, XDH | 4.5361 |
Endocytosis_Homo sapiens_hsa04144 | SMAD3, SRC, KIT, KDR, MET, EGFR, IGF1R, HSPA1A | 4.4978 |
Proteoglycans in cancer_Homo sapiens_hsa05205 | SRC, MMP2, KDR, MMP9, MET, EGFR, IGF1R | 4.1944 |
MicroRNAs in cancer_Homo sapiens_hsa05206 | DNMT1, ABCB1, BCL2, PIM1, CYP1B1, MMP9, MET, EGFR | 4.1453 |
Ras signaling pathway_Homo sapiens_hsa04014 | INSR, KIT, KDR, TEK, MET, EGFR, IGF1R | 3.9901 |
PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | INSR, KIT, KDR, BCL2, TEK, MET, EGFR, IGF1R | 3.8133 |
Estrogen signaling pathway_Homo sapiens_hsa04915 | SRC, MMP2, MMP9, EGFR, HSPA1A | 3.7535 |
Tryptophan metabolism_Homo sapiens_hsa00380 | MAOB, CYP1A2, CYP1A1, CYP1B1 | 3.9901 |
HIF-1 signaling pathway_Homo sapiens_hsa04066 | INSR, BCL2, TEK, EGFR, IGF1R | 3.6981 |
Focal adhesion_Homo sapiens_hsa04510 | SRC, KDR, BCL2, MET, EGFR, IGF1R | 3.3562 |
Central carbon metabolism in cancer_Homo sapiens_hsa05230 | FLT3, KIT, MET, EGFR | 3.2517 |
AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | SMAD3, MMP2, BCL2, PIM1 | 2.6676 |
Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | CBR1, CYP1A2, CYP1A1, CYP1B1 | 3.1515 |
PPAR signaling pathway_Homo sapiens_hsa03320 | FABP3, FABP4, MMP1, PPARA | 3.225 |
Serotonergic synapse_Homo sapiens_hsa04726 | APP, MAOB, ALOX5, ALOX15 | 2.5154 |
Chemical carcinogenesis_Homo sapiens_hsa05204 | CBR1, CYP1A2, CYP1A1, CYP1B1 | 2.9965 |
FoxO signaling pathway_Homo sapiens_hsa04068 | SMAD3, INSR, EGFR, IGF1R | 2.2864 |
Hepatitis B_Homo sapiens_hsa05161 | SMAD3, SRC, BCL2, MMP9 | 2.1821 |
Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | FABP4, INSR, ADORA1 | 2.3142 |
Acute myeloid leukemia_Homo sapiens_hsa05221 | FLT3, KIT, PIM1 | 2.3087 |
Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | FLT3, KIT, KDR, MET, EGFR | 2.1092 |
cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | ADORA3, INSR, ADORA1, PDE5A | 2.0228 |
Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | INSR, IGF1R, HSPA1A | 2.2097 |
Arachidonic acid metabolism_Homo sapiens_hsa00590 | CBR1, ALOX5, ALOX15 | 2.2345 |
Melanoma_Homo sapiens_hsa05218 | MET, EGFR, IGF1R | 2.1222 |
Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | SRC, MET, EGFR | 2.1625 |
Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | FLT3, MMP9, MET, IGF1R | 1.93 |
Prostate cancer_Homo sapiens_hsa05215 | BCL2, EGFR, IGF1R | 1.9165 |
GnRH signaling pathway_Homo sapiens_hsa04912 | SRC, MMP2, EGFR | 1.9007 |
Gap junction_Homo sapiens_hsa04540 | SRC, TUBB3, EGFR | 1.919 |
Toxoplasmosis_Homo sapiens_hsa05145 | ALOX5, BCL2, HSPA1A | 1.648 |
Phospholipase D signaling pathway_Homo sapiens_hsa04072 | INSR, KIT, EGFR | 1.4312 |
Sphingolipid signaling pathway_Homo sapiens_hsa04071 | ADORA3, BCL2, ADORA1 | 1.6373 |
Epstein-Barr virus infection_Homo sapiens_hsa05169 | CSNK2A1, BCL2, HSPA1A | 1.1364 |
cAMP signaling pathway_Homo sapiens_hsa04024 | HCAR2, ADORA1, PPARA | 1.1455 |
MAPK signaling pathway_Homo sapiens_hsa04010 | DUSP3, EGFR, HSPA1A | 0.9492 |
Glioma_Homo sapiens_hsa05214 | EGFR, IGF1R | 1.259 |
VEGF signaling pathway_Homo sapiens_hsa04370 | SRC, KDR | 1.2853 |
ErbB signaling pathway_Homo sapiens_hsa04012 | SRC, EGFR | 1.0787 |
Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | GPR35, ADORA3, ADORA1 | 0.8887 |
Melanogenesis_Homo sapiens_hsa04916 | KIT, TYR | 1.004 |
Cholinergic synapse_Homo sapiens_hsa04725 | ACHE, BCL2 | 0.9492 |
Insulin resistance_Homo sapiens_hsa04931 | INSR, PPARA | 0.95 |
Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | INSR, IGF1R | 1.0459 |
Pancreatic cancer_Homo sapiens_hsa05212 | SMAD3, EGFR | 1.2548 |
Colorectal cancer_Homo sapiens_hsa05210 | SMAD3, BCL2 | 1.2807 |
Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | SRC, MET | 1.1455 |
Hematopoietic cell lineage_Homo sapiens_hsa04640 | FLT3, KIT | 1.0769 |
Rheumatoid arthritis_Homo sapiens_hsa05323 | MMP1, TEK | 1.0663 |
NF-kappa B signaling pathway_Homo sapiens_hsa04064 | CSNK2A1, BCL2 | 1.0474 |
Glycerolipid metabolism_Homo sapiens_hsa00561 | AKR1B10, AKR1B1 | 1.3036 |
Measles_Homo sapiens_hsa05162 | CSNK2A1, HSPA1A | 0.8309 |
Hepatitis C_Homo sapiens_hsa05160 | PPARA, EGFR | 0.8416 |
AMPK signaling pathway_Homo sapiens_hsa04152 | INSR, IGF1R | 0.8887 |
Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | MAOB, CYP1A2 | 1.2267 |
Retinol metabolism_Homo sapiens_hsa00830 | CYP1A2, CYP1A1 | 1.259 |
Leukocyte transendothelial migration_Homo sapiens_hsa04670 | MMP2, MMP9 | 0.9147 |
Tight junction_Homo sapiens_hsa04530 | CSNK2A1, SRC | 0.8256 |
Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | SMAD3, IGF1R | 0.8213 |
Wnt signaling pathway_Homo sapiens_hsa04310 | SMAD3, CSNK2A1 | 0.8213 |
Bile secretion_Homo sapiens_hsa04976 | ABCB1, CA2 | 1.2115 |
Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | INSR, PPARA | 0.7975 |
Jak-STAT signaling pathway_Homo sapiens_hsa04630 | BCL2, PIM1 | 0.7747 |
Oxytocin signaling pathway_Homo sapiens_hsa04921 | SRC, EGFR | 0.7747 |
Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | BCL2, HSPA1A | 0.7409 |
Alzheimer's disease_Homo sapiens_hsa05010 | BACE1, APP | 0.7409 |
Purine metabolism_Homo sapiens_hsa00230 | PDE5A, XDH | 0.7215 |
Tuberculosis_Homo sapiens_hsa05152 | SRC, BCL2 | 0.7183 |
Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | SRC, EGFR | 0.6392 |
Viral carcinogenesis_Homo sapiens_hsa05203 | SRC | 0.311 |
HTLV-I infection_Homo sapiens_hsa05166 | SMAD3, TERT | 0.5632 |
Herpes simplex infection_Homo sapiens_hsa05168 | CSNK2A1 | 0.3372 |
Calcium signaling pathway_Homo sapiens_hsa04020 | EGFR | 0.343 |
Alcoholism_Homo sapiens_hsa05034 | MAOB | 0.343 |
Influenza A_Homo sapiens_hsa05164 | HSPA1A | 0.3462 |
Chemokine signaling pathway_Homo sapiens_hsa04062 | SRC | 0.3367 |
Hippo signaling pathway_Homo sapiens_hsa04390 | SMAD3 | 0.3853 |
Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | BCL2 | 0.3927 |
Phagosome_Homo sapiens_hsa04145 | TUBB3 | 0.3853 |
Apoptosis_Homo sapiens_hsa04210 | BCL2 | 0.4086 |
Insulin signaling pathway_Homo sapiens_hsa04910 | INSR | 0.4086 |
Spliceosome_Homo sapiens_hsa03040 | HSPA1A | 0.4176 |
Platelet activation_Homo sapiens_hsa04611 | SRC | 0.4353 |
Neurotrophin signaling pathway_Homo sapiens_hsa04722 | BCL2 | 0.4374 |
Oocyte meiosis_Homo sapiens_hsa04114 | IGF1R | 0.4353 |
Cell cycle_Homo sapiens_hsa04110 | SMAD3 | 0.4353 |
Axon guidance_Homo sapiens_hsa04360 | MET | 0.43 |
Dopaminergic synapse_Homo sapiens_hsa04728 | MAOB | 0.4277 |
Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | SRC | 0.4401 |
TNF signaling pathway_Homo sapiens_hsa04668 | MMP9 | 0.4621 |
Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | IGF1R | 0.4909 |
Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | SMAD3 | 0.4791 |
Choline metabolism in cancer_Homo sapiens_hsa05231 | EGFR | 0.4865 |
Glucagon signaling pathway_Homo sapiens_hsa04922 | PPARA | 0.4865 |
Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | SRC | 0.4909 |
Glycerophospholipid metabolism_Homo sapiens_hsa00564 | ACHE | 0.4921 |
Pancreatic secretion_Homo sapiens_hsa04972 | CA2 | 0.4917 |
Morphine addiction_Homo sapiens_hsa05032 | ADORA1 | 0.5047 |
TGF-beta signaling pathway_Homo sapiens_hsa04350 | SMAD3 | 0.5206 |
GABAergic synapse_Homo sapiens_hsa04727 | SRC | 0.5102 |
Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | CSNK2A1 | 0.5095 |
Small cell lung cancer_Homo sapiens_hsa05222 | BCL2 | 0.5153 |
Peroxisome_Homo sapiens_hsa04146 | XDH | 0.5214 |
Chronic myeloid leukemia_Homo sapiens_hsa05220 | SMAD3 | 0.5556 |
Prolactin signaling pathway_Homo sapiens_hsa04917 | SRC | 0.5572 |
Complement and coagulation cascades_Homo sapiens_hsa04610 | F10 | 0.5366 |
Gastric acid secretion_Homo sapiens_hsa04971 | CA2 | 0.5542 |
Antigen processing and presentation_Homo sapiens_hsa04612 | HSPA1A | 0.5427 |
Adipocytokine signaling pathway_Homo sapiens_hsa04920 | PPARA | 0.5632 |
Renal cell carcinoma_Homo sapiens_hsa05211 | MET | 0.5754 |
Amphetamine addiction_Homo sapiens_hsa05031 | MAOB | 0.5735 |
Renin secretion_Homo sapiens_hsa04924 | ADORA1 | 0.5774 |
Shigellosis_Homo sapiens_hsa05131 | SRC | 0.5774 |
Long-term depression_Homo sapiens_hsa04730 | IGF1R | 0.5967 |
Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | SMAD3 | 0.5774 |
Galactose metabolism_Homo sapiens_hsa00052 | AKR1B10, AKR1B1 | 1.8038 |
Tyrosine metabolism_Homo sapiens_hsa00350 | MAOB, TYR | 1.6929 |
Non-small cell lung cancer_Homo sapiens_hsa05223 | EGFR | 0.6198 |
Legionellosis_Homo sapiens_hsa05134 | HSPA1A | 0.6229 |
Endometrial cancer_Homo sapiens_hsa05213 | EGFR | 0.6368 |
Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | TUBB3 | 0.6229 |
Linoleic acid metabolism_Homo sapiens_hsa00591 | ALOX15, CYP1A2 | 1.8222 |
Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | AKR1B10, AKR1B1 | 1.679 |
Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | BCL2 | 0.6392 |
Malaria_Homo sapiens_hsa05144 | MET | 0.6432 |
Cocaine addiction_Homo sapiens_hsa05030 | MAOB | 0.6432 |
Arginine and proline metabolism_Homo sapiens_hsa00330 | MAOB | 0.6394 |
Type II diabetes mellitus_Homo sapiens_hsa04930 | INSR | 0.6432 |
Fructose and mannose metabolism_Homo sapiens_hsa00051 | AKR1B10, AKR1B1 | 1.759 |
Drug metabolism - other enzymes_Homo sapiens_hsa00983 | XDH | 0.655 |
Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | CA2, CA4 | 1.9642 |
ABC transporters_Homo sapiens_hsa02010 | ABCB1 | 0.6637 |
Cysteine and methionine metabolism_Homo sapiens_hsa00270 | DNMT1 | 0.6594 |
Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | INSR | 0.7033 |
Prion diseases_Homo sapiens_hsa05020 | HSPA1A | 0.7331 |
Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | MAOB | 0.6977 |
Dorso-ventral axis formation_Homo sapiens_hsa04320 | EGFR | 0.8041 |
Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | FUT7 | 0.768 |
Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | FUT7 | 0.8091 |
Collecting duct acid secretion_Homo sapiens_hsa04966 | CA2 | 0.8041 |
Histidine metabolism_Homo sapiens_hsa00340 | MAOB | 0.8256 |
Phenylalanine metabolism_Homo sapiens_hsa00360 | MAOB | 0.9285 |
Folate biosynthesis_Homo sapiens_hsa00790 | ALPL | 0.9851 |
Caffeine metabolism_Homo sapiens_hsa00232 | CYP1A2, XDH | 3.129 |